Advertisement

Management of Status Epilepticus

  • K. N. Gopalakrishna
  • M. Radhakrishnan
Chapter
  • 43 Downloads

Abstract

A 34-year-old male patient presented to casualty with tonic-clonic seizures. He was treated with two doses of 0.1 mg/kg of intravenous (IV) lorazepam with in 5 min apart with oxygen supplementation and airway support, in addition, Phenytoin 20 mg/kg IV was administered over 30 min. On examination, the patient was found unresponsive and continued to have seizures. The patient was intubated for airway protection, and IV Levetiracetam 30 mg/kg bolus was administered. The patient was put on mechanical ventilation, and he continued to have seizures. Intravenous anesthetic midazolam 0.2 mg/kg bolus was given followed by 0.2 mg/kg/h, titrated up to 0.6 mg/kg. Electroencephalogram (EEG) monitoring instituted to monitor for seizure activity. Laboratory workup was with in normal limit, and computed tomography (CT) brain did not reveal any intracranial bleed/mass or features of raised intracranial pressure. The patient continued to have clinical seizures once in every 40 min, for which a thiopental sodium bolus of 4 mg/Kg followed by infusion at 5 mg/kg/h was initiated. The patient continued to have focal motor seizures and EEG showed a generalization of the seizure (Fig. 13.1a). Ketamine 1 mg/kg bolus followed by 2 mg/kg/h of infusion was instituted for control of seizures clinically and electroencephalographically (Fig. 13.1b).

References

  1. 1.
    Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17(1):3–23.CrossRefGoogle Scholar
  2. 2.
    Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S, et al. A definition and classification of status epilepticus--Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015;56(10):1515–23.CrossRefGoogle Scholar
  3. 3.
    Caricato A, Melchionda I, Antonelli M. Continuous electroencephalography monitoring in adults in the intensive care unit. Crit Care. 2018;22(1):75.CrossRefGoogle Scholar
  4. 4.
    Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons BF. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol. 2002;59(2):205–10.CrossRefGoogle Scholar
  5. 5.
    Shorvon S, Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain. 2011;134(Pt 10):2802–18.CrossRefGoogle Scholar
  6. 6.
    Kalita J, Nair PP, Misra UK. A clinical, radiological and outcome study of status epilepticus from India. J Neurol. 2010;257(2):224–9.CrossRefGoogle Scholar
  7. 7.
    Santhosh NS, Sinha S, Satishchandra P. Epilepsy: Indian perspective. Ann Indian Acad Neurol. 2014;17(Suppl 1):S3–s11.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Bromfield EB, Cavazos JE, Sirven JI. Basic mechanisms underlying seizures and epilepsy. Landover: American Epilepsy Society; 2006.Google Scholar
  9. 9.
    Arancibia-Carcamo IL, Kittler JT. Regulation of GABA(A) receptor membrane trafficking and synaptic localization. Pharmacol Ther. 2009;123(1):17–31.CrossRefGoogle Scholar
  10. 10.
    Cock HR, Tong X, Hargreaves IP, Heales SJ, Clark JB, Patsalos PN, et al. Mitochondrial dysfunction associated with neuronal death following status epilepticus in rat. Epilepsy Res. 2002;48(3):157–68.CrossRefGoogle Scholar
  11. 11.
    Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde BW, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia. 2010;51(4):676–85.CrossRefGoogle Scholar
  12. 12.
    Varelas PN, Mirski MA. Seizures in the adult intensive care unit. J Neurosurg Anesthesiol. 2001;13(2):163–75.CrossRefGoogle Scholar
  13. 13.
    Gullapalli B. Status epilepticus. In: Suarez JI, editor. Critical care neurology and neurosurgery. Totowa: Humana Press; 2004. p. 449–68.CrossRefGoogle Scholar
  14. 14.
    Al-Mufti F, Claassen J. Neurocritical care: status epilepticus review. Crit Care Clin. 2014;30(4):751–64.CrossRefGoogle Scholar
  15. 15.
    Claassen J, Goldstein JN. Emergency neurological life support: status epilepticus. Neurocrit Care. 2017;27(Suppl 1):152–8.CrossRefGoogle Scholar
  16. 16.
    Unterberger I. Status epilepticus: do treatment guidelines make sense? J Clin Neurophysiol. 2016;33(1):10–3.CrossRefGoogle Scholar
  17. 17.
    Shorvon S. The treatment of status epilepticus. Curr Opin Neurol. 2011;24(2):165–70.CrossRefGoogle Scholar
  18. 18.
    Zeiler FA, Zeiler KJ, Teitelbaum J, Gillman LM, West M. Modern inhalational anesthetics for refractory status epilepticus. Can J Neurol Sci. 2015;42(2):106–15.CrossRefGoogle Scholar
  19. 19.
    Alldredge BK, Gelb AM, Isaacs SM, Corry MD, Allen F, Ulrich S, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med. 2001;345(9):631–7.CrossRefGoogle Scholar
  20. 20.
    Claassen J, Lokin JK, Fitzsimmons BF, Mendelsohn FA, Mayer SA. Predictors of functional disability and mortality after status epilepticus. Neurology. 2002;58(1):139–42.CrossRefGoogle Scholar
  21. 21.
    Novy J, Logroscino G, Rossetti AO. Refractory status epilepticus: a prospective observational study. Epilepsia. 2010;51(2):251–6.CrossRefGoogle Scholar
  22. 22.
    Logroscino G, Hesdorffer DC, Cascino GD, Annegers JF, Bagiella E, Hauser WA. Long-term mortality after a first episode of status epilepticus. Neurology. 2002;58(4):537–41.CrossRefGoogle Scholar
  23. 23.
    Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia. 2002;43(2):146–53.CrossRefGoogle Scholar
  24. 24.
    Claassen J, Hirsch LJ, Emerson RG, Bates JE, Thompson TB, Mayer SA. Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus. Neurology. 2001;57(6):1036–42.CrossRefGoogle Scholar
  25. 25.
    Rossetti AO, Reichhart MD, Schaller MD, Despland PA, Bogousslavsky J. Propofol treatment of refractory status epilepticus: a study of 31 episodes. Epilepsia. 2004;45(7):757–63.CrossRefGoogle Scholar
  26. 26.
    Hocker SE. Status Epilepticus. Continuum (Minneap Minn). 2015;21(5 Neurocritical Care):1362–83.Google Scholar
  27. 27.
    Pichler M, Hocker S. Management of status epilepticus. In: Wijdicks EFM, Kramer AH, editors. Hand book of clinical neurology: critical care neurology part 1, vol. 140. Amsterdam: Elsevier; 2017. p. 131–51.CrossRefGoogle Scholar

Copyright information

© The Editor(s) (if applicable) and The Author(s)  2020

Authors and Affiliations

  • K. N. Gopalakrishna
    • 1
  • M. Radhakrishnan
    • 1
  1. 1.National Institute of Mental Health and NeurosciencesBengaluruIndia

Personalised recommendations